In8bio to present at the td cowen 45th annual health care conference

New york, feb. 26, 2025 (globe newswire) -- in8bio, inc . (nasdaq: inab), a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta t cell therapies, today announced that william ho, ceo and co-founder, will be presenting at the td cowen 45th  annual health care conference on monday, march 3, 2025, at 10:30 a.m.
COWN Ratings Summary
Quant
COWN Quant Ranking
Sector
Industry
Quant Rating
Quant Score